Clinical applications of glycosylated haemoglobin

Abstract

Glycosylated haemoglobin (HbA1c) has been in use since 1980s as the 'gold standard' for monitoring glycaemic control and as a predictor of diabetic complications. Even though several conditions, such as, haemolytic anaemia (lowers HbA1c) and aplastic anaemia (raises HbA1c) tend to confound and interfere with HbA1c measurement, in most circumstances HbA1c is… (More)

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Reddy2013ClinicalAO, title={Clinical applications of glycosylated haemoglobin}, author={S. Aparna Reddy and Alok Sachan}, year={2013} }